Ayr Wellness Future Growth
Future criteria checks 0/6
Ayr Wellness is forecast to grow earnings and revenue by 37.2% and 4% per annum respectively while EPS is expected to grow by 36% per annum.
Key information
37.2%
Earnings growth rate
36.0%
EPS growth rate
| Pharmaceuticals earnings growth | 61.7% |
| Revenue growth rate | 4.0% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 09 Dec 2024 |
Recent future growth updates
Recent updates
Ayr Wellness Inc. (CSE:AYR.A) Not Doing Enough For Some Investors As Its Shares Slump 30%
Jan 01
Ayr Wellness Inc.'s (CSE:AYR.A) 29% Share Price Surge Not Quite Adding Up
Nov 03Ayr Wellness (CSE:AYR.A) Has Debt But No Earnings; Should You Worry?
Oct 23Ayr Wellness Inc. (CSE:AYR.A) Not Doing Enough For Some Investors As Its Shares Slump 28%
Aug 28Does Ayr Wellness (CSE:AYR.A) Have A Healthy Balance Sheet?
Jul 17Ayr Wellness Inc.'s (CSE:AYR.A) Shares Not Telling The Full Story
May 24Is Ayr Wellness Inc. (CSE:AYR.A) Worth CA$2.1 Based On Its Intrinsic Value?
Dec 22Is Ayr Wellness (CSE:AYR.A) Using Debt Sensibly?
Oct 06Ayr Wellness Inc.'s (CSE:AYR.A) Share Price Boosted 33% But Its Business Prospects Need A Lift Too
Sep 01Ayr Wellness Inc. (CSE:AYR.A) Stock Catapults 33% Though Its Price And Business Still Lag The Industry
Sep 01Is There An Opportunity With Ayr Wellness Inc.'s (CSE:AYR.A) 33% Undervaluation?
Jul 11What You Need To Know About The Ayr Wellness Inc. (CSE:AYR.A) Analyst Downgrade Today
Aug 19Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2027 | 528 | N/A | N/A | N/A | 1 |
| 12/31/2026 | 510 | N/A | -7 | 10 | 2 |
| 12/31/2025 | 481 | -138 | 10 | 23 | 5 |
| 12/31/2024 | 464 | -226 | -5 | 26 | 6 |
| 9/30/2024 | 465 | -223 | -10 | 21 | N/A |
| 6/30/2024 | 465 | -191 | -7 | 25 | N/A |
| 3/31/2024 | 464 | -183 | -12 | 26 | N/A |
| 12/31/2023 | 464 | -86 | -12 | 27 | N/A |
| 9/30/2023 | 463 | -190 | -12 | 26 | N/A |
| 6/30/2023 | 457 | -206 | -36 | 6 | N/A |
| 3/31/2023 | 440 | -211 | -59 | -3 | N/A |
| 12/31/2022 | 421 | -207 | -111 | -34 | N/A |
| 9/30/2022 | 419 | -51 | -152 | -40 | N/A |
| 6/30/2022 | 406 | -21 | -165 | -40 | N/A |
| 3/31/2022 | 399 | -6 | -148 | -29 | N/A |
| 12/31/2021 | 358 | -17 | -128 | -28 | N/A |
| 9/30/2021 | 294 | -42 | -82 | -15 | N/A |
| 6/30/2021 | 243 | -38 | -43 | -3 | N/A |
| 3/31/2021 | 180 | -27 | -15 | 8 | N/A |
| 12/31/2020 | 155 | -25 | 21 | 35 | N/A |
| 9/30/2020 | 140 | -41 | 18 | 32 | N/A |
| 6/30/2020 | 126 | -16 | -1 | 18 | N/A |
| 3/31/2020 | 109 | -42 | -8 | 11 | N/A |
| 12/31/2019 | 75 | -164 | -11 | 4 | N/A |
| 9/30/2019 | 43 | -191 | -7 | -1 | N/A |
| 6/30/2019 | 11 | -242 | 0 | 0 | N/A |
| 3/31/2019 | N/A | -209 | -1 | -1 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: AYR.A is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: AYR.A is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: AYR.A is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: AYR.A's revenue (4% per year) is forecast to grow slower than the Canadian market (7.1% per year).
High Growth Revenue: AYR.A's revenue (4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if AYR.A's Return on Equity is forecast to be high in 3 years time
Discover growth companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/21 23:36 |
| End of Day Share Price | 2025/01/21 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Ayr Wellness Inc. is covered by 13 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Frederico Yokota Choucair Gomes | ATB Capital Markets |
| Kenric Tyghe | ATB Capital Markets |
| Russell Stanley | Beacon Securities Limited |